JP2018520150A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520150A5
JP2018520150A5 JP2017567701A JP2017567701A JP2018520150A5 JP 2018520150 A5 JP2018520150 A5 JP 2018520150A5 JP 2017567701 A JP2017567701 A JP 2017567701A JP 2017567701 A JP2017567701 A JP 2017567701A JP 2018520150 A5 JP2018520150 A5 JP 2018520150A5
Authority
JP
Japan
Prior art keywords
mir
nucleic acid
pharmaceutical composition
inhibitor
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017567701A
Other languages
English (en)
Japanese (ja)
Other versions
JP7032140B2 (ja
JP2018520150A (ja
Filing date
Publication date
Priority claimed from PCT/IB2015/001253 external-priority patent/WO2017006145A1/en
Application filed filed Critical
Publication of JP2018520150A publication Critical patent/JP2018520150A/ja
Publication of JP2018520150A5 publication Critical patent/JP2018520150A5/ja
Application granted granted Critical
Publication of JP7032140B2 publication Critical patent/JP7032140B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017567701A 2015-07-03 2016-07-01 嚢胞性線維症の処置のための方法及び医薬組成物 Expired - Fee Related JP7032140B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2015/001253 2015-07-03
PCT/IB2015/001253 WO2017006145A1 (en) 2015-07-03 2015-07-03 Methods and pharmaceutical compositions for the treatment of cystic fibrosis
PCT/EP2016/065565 WO2017005646A1 (en) 2015-07-03 2016-07-01 Methods and pharmaceutical compositions for the treatment of cystic fibrosis

Publications (3)

Publication Number Publication Date
JP2018520150A JP2018520150A (ja) 2018-07-26
JP2018520150A5 true JP2018520150A5 (https=) 2019-06-27
JP7032140B2 JP7032140B2 (ja) 2022-03-08

Family

ID=54347575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567701A Expired - Fee Related JP7032140B2 (ja) 2015-07-03 2016-07-01 嚢胞性線維症の処置のための方法及び医薬組成物

Country Status (5)

Country Link
US (1) US11130950B2 (https=)
EP (1) EP3317412B1 (https=)
JP (1) JP7032140B2 (https=)
ES (1) ES2856555T3 (https=)
WO (2) WO2017006145A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019076919A1 (en) 2017-10-17 2019-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) COMBINED TREATMENT OF CYSTIC FIBROSIS
WO2021074657A1 (en) 2019-10-17 2021-04-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination treatment for cystic fibrosis
WO2023152369A1 (en) * 2022-02-14 2023-08-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Nucleic acid mir-9 inhibitor for the treatment of cystic fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948926A (zh) 2014-03-24 2014-07-30 江苏大学 miR-9抑制剂在制备用于抑制肿瘤生长药物中的用途

Similar Documents

Publication Publication Date Title
McDermott et al. The therapeutic potential of microRNAs: disease modulators and drug targets
HK1209781A1 (en) Oligonucleotide-based inhibitors comprising locked nucleic acid motif
JP2018531037A5 (https=)
JP2008509670A5 (https=)
JP2013510561A5 (https=)
WO2005047477A3 (en) Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
JP2018529732A5 (https=)
JP2013126996A5 (https=)
JP2014527401A5 (https=)
HRP20211971T1 (hr) Pripravci i postupci za inhibiciju ekspresije gena hao1 (hidroksikiselina oksidaza 1 (glikolat oksidaza))
JP7566741B2 (ja) プログラム可能なｓｉＲＮＡ及びその使用
JP2010539990A (ja) アンチセンス転写物を標的とするａｇＲＮＡおよびギャップマーを用いた遺伝子発現の調節方法
WO2009105260A3 (en) Ultra-small rnas as toll-like receptor-3 antagonists
WO2006047683A3 (en) Antisense antiviral compound and method for treating influenza viral infection
EP2495248A4 (en) BRIDGED ARTIFICIAL NUCLEOSIDE AND NUCLEOTIDE
EA201100812A1 (ru) Фармацевтическая композиция
WO2011056005A3 (ko) 안티센스 가닥에 의한 오프-타겟 효과를 최소화한 신규한 ｓｉＲＮＡ 구조 및 그 용도
Philippen et al. Antisense MicroRNA therapeutics in cardiovascular disease: quo vadis?
EP2002018A4 (en) ANTIVIRAL ANTISENSE COMPOUND AND METHOD FOR THE TREATMENT OF ARENA VIRUS INFECTION
JP2017528441A5 (https=)
WO2012083005A3 (en) Microrna inhibitors comprising locked nucleotides
BR112014010134A2 (pt) inibição da expressão genética viral
CR20200453A (es) Uso de inhibidores de fubp1 para el tratamiento de infección de virús de hepatitis b
JP2016534031A5 (https=)
Heinrich et al. Regulation of miR-17-92a cluster processing by the microRNA binding protein SND1